Preparation for the prevention and/or treatment of vascular disorders
First Claim
Patent Images
1. A method for treating a person suffering from dementia syndrome or being at risk of developing dementia syndrome, comprising administering to the person a preparation comprising:
- a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA);
b) at least two phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and
c) folic acid, and vitamin B6 wherein the preparation comprises 120-2000 mg per daily dosage of EPA and DHA collectively, of which at least 50 mg of the daily dosage is DHA.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
- fraction a) consisting of long chain polyunsaturated fatty acids;
- fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine.
- fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
-
Citations
20 Claims
-
1. A method for treating a person suffering from dementia syndrome or being at risk of developing dementia syndrome, comprising administering to the person a preparation comprising:
-
a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); b) at least two phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) folic acid, and vitamin B6 wherein the preparation comprises 120-2000 mg per daily dosage of EPA and DHA collectively, of which at least 50 mg of the daily dosage is DHA. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification